GlassScriptPhysician profile
Samir N Patel
NPI 1922263961
$13,702.14
in general payments reported to CMS, 2019-2025
20 companies · $2,593 in 2025
The $2,593 reported for 2025 was more than what 98% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $480 · 2020: $136 · 2021: $930 · 2022: $2,170 · 2023: $894 · 2024: $6,499 · 2025: $2,593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,803 · Consulting Fee: $3,450 · Travel and Lodging: $2,140 · Honoraria: $350 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $225 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,803.07 |
| Consulting Fee | $3,450.00 |
| Travel and Lodging | $2,140.33 |
| Honoraria | $350.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $225.00 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $3,394.41 | 2024-2025 | Xdemvy |
| Coopervision INC. | $2,573.09 | 2019-2025 | Misight Contact Lens, Clariti Contact Lens, Myday Contact Lens |
| Bausch & Lomb Americas INC. | $2,373.84 | 2022-2025 | Infuse, Miebo, Vyzulta |
| Alcon Vision LLC | $1,907.84 | 2019-2025 | Total30, Precision 1, Precision7 |
| Topcon Healthcare, INC. | $1,100.00 | 2024 | |
| Johnson & Johnson Vision Care, INC. | $877.48 | 2020-2025 | Acuvue |
| Oyster Point Pharma, INC. | $635.56 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $219.41 | 2019-2020 | |
| Emd Serono, INC. | $101.39 | 2019 | |
| Dompe US, INC. | $81.14 | 2025 | Oxervate |
| Glaukos Corporation | $76.75 | 2022 | |
| Abbvie INC. | $73.34 | 2022-2023 | |
| Synergeyes, INC. | $71.58 | 2022 | |
| Allergan, INC. | $69.97 | 2021 | |
| Harrow Eye, LLC | $56.06 | 2024-2025 | Vevye |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lombart Brothers, INC. | $22.27 | 2023 | Opd-III |
| Novartis Pharmaceuticals Corporation | $20.76 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Sight Sciences, INC. | $14.41 | 2024 | Tearcare System |
| Shire North American Group INC | $13.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.